ACCESS CHINA San Diego Forum: Facilitating Partnerships and Strategic Networking for Pharma and Biotech

The ACCESS CHINA@BIO East-Meet-West Reception, hosted on June 2^nd, 2024, in San Diego, exceeded expectations, offering an evening filled with heated discussions, valuable networking, and potential partnership opportunities.

Attendees were greeted with a lively atmosphere, as pharma/biotech executives, BDs and investors engaged in meaningful talks on the future of healthcare innovations.

The exchange of ideas was fueled by premium wine and beer, creating an environment conducive to collaboration and networking.

With over 100 Chinese and international pharmaceutical companies represented, including 40+ Chinese companies and 40+ overseas companies, the reception provided a diverse and dynamic platform for cross-border exchanges.

Attendees seized the opportunity to explore potential partnerships and gain insights into emerging trends and opportunities in the global pharmaceutical landscape.

The event underscored the importance of fostering international collaborations in driving advancements within the pharmaceutical and biotechnology industries. Participants left the reception inspired and energized, equipped with new perspectives and connections to propel their organizations forward.

Photos of YAFO booth during BIO:

We extend our sincere gratitude for your participation and contribution, making the event a resounding success. Here’s a preview of our upcoming events:

2024-09 ACCESS CHINA Autumn Roadshow, Virtual & Yunnan
2025-01 ACCESS CHINA @ JPM Week, Virtual & San Francisco

We eagerly anticipate your participation in our upcoming online events and in-person conferences. Let’s collaborate to advance pharmaceutical innovation globally!

About YAFO Capital

Founded in 2013, YAFO Capital is a Shanghai based boutique investment and advisory firm, with professional team in our China, U.S., and London offices. Partnering with Pharmaceutical companies, YAFO Fund mainly invests in global assets. YAFO Life Sciences is a leading advisory boutique focused on asset transactions. YAFO has built a strong proven track record and closed dozens of in-licensing and out-licensing transactions with global pharma and biotech companies. YAFO has been ranked as the No. 1 advisor for China cross border licensing transactions in the past three years. For more information, please visit http://www.yafocapital.com

Follow Us For More Event Information: